Cargando…

Ultrashort Door‐to‐Needle Time for Intravenous Thrombolysis Is Safer and Improves Outcome in the Czech Republic: Nationwide Study 2004 to 2019

BACKGROUND: The benefit of intravenous thrombolysis is time dependent. It remains unclear, however, whether dramatic shortening of door‐to‐needle time (DNT) among different types of hospitals nationwide does not compromise safety and still improves outcome. METHODS AND RESULTS: Multifaceted interven...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikulík, Robert, Bar, Michal, Bělašková, Silvie, Černík, David, Fiksa, Jan, Herzig, Roman, Jura, René, Jurák, Lubomír, Klečka, Lukáš, Neumann, Jiří, Ostrý, Svatopluk, Šaňák, Daniel, Ševčík, Petr, Škoda, Ondřej, Šrámek, Martin, Tomek, Aleš, Václavík, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238542/
https://www.ncbi.nlm.nih.gov/pubmed/35574953
http://dx.doi.org/10.1161/JAHA.121.023524
_version_ 1784737078015164416
author Mikulík, Robert
Bar, Michal
Bělašková, Silvie
Černík, David
Fiksa, Jan
Herzig, Roman
Jura, René
Jurák, Lubomír
Klečka, Lukáš
Neumann, Jiří
Ostrý, Svatopluk
Šaňák, Daniel
Ševčík, Petr
Škoda, Ondřej
Šrámek, Martin
Tomek, Aleš
Václavík, Daniel
author_facet Mikulík, Robert
Bar, Michal
Bělašková, Silvie
Černík, David
Fiksa, Jan
Herzig, Roman
Jura, René
Jurák, Lubomír
Klečka, Lukáš
Neumann, Jiří
Ostrý, Svatopluk
Šaňák, Daniel
Ševčík, Petr
Škoda, Ondřej
Šrámek, Martin
Tomek, Aleš
Václavík, Daniel
author_sort Mikulík, Robert
collection PubMed
description BACKGROUND: The benefit of intravenous thrombolysis is time dependent. It remains unclear, however, whether dramatic shortening of door‐to‐needle time (DNT) among different types of hospitals nationwide does not compromise safety and still improves outcome. METHODS AND RESULTS: Multifaceted intervention to shorten DNT was introduced at a national level, and prospectively collected data from a registry between 2004 and 2019 were analyzed. Generalized estimating equation was used to identify the association between DNT and outcomes independently from prespecified baseline variables. The primary outcome was modified Rankin score 0 to 1 at 3 months, and secondary outcomes were parenchymal hemorrhage/intracerebral hemorrhage (ICH), any ICH, and death. Of 31 316 patients treated with intravenous thrombolysis alone, 18 861 (60%) had available data: age 70±13 years, National Institutes of Health Stroke Scale at baseline (median, 8; interquartile range, 5–14), and 45% men. DNT groups 0 to 20 minutes, 21 to 40 minutes, 41 to 60 minutes, and >60 minutes had 3536 (19%), 5333 (28%), 4856 (26%), and 5136 (27%) patients. National median DNT dropped from 74 minutes in 2004 to 22 minutes in 2019. Shorter DNT had proportional benefit: it increased the odds of achieving modified Rankin score 0 to 1 and decreased the odds of parenchymal hemorrhage/ICH, any ICH, and mortality. Patients with DNT ≤20 minutes, 21 to 40 minutes, and 41 to 60 minutes as compared with DNT >60 minutes had adjusted odds ratios for modified Rankin score 0 to 1 of the following: 1.30 (95% CI, 1.12–1.51), 1.33 (95% CI, 1.15–1.54), and 1.15 (95% CI, 1.02–1.29), and for parenchymal hemorrhage/ICH: 0.57 (95% CI, 0.45–0.71), 0.76 (95% CI, 0.61–0.94), 0.83 (95% CI, 0.70–0.99), respectively. CONCLUSIONS: Ultrashort initiation of thrombolysis is feasible, improves outcome, and makes treatments safer because of fewer intracerebral hemorrhages. Stroke management should be optimized to initiate thrombolysis as soon as possible optimally within 20 minutes from arrival to a hospital.
format Online
Article
Text
id pubmed-9238542
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92385422022-06-30 Ultrashort Door‐to‐Needle Time for Intravenous Thrombolysis Is Safer and Improves Outcome in the Czech Republic: Nationwide Study 2004 to 2019 Mikulík, Robert Bar, Michal Bělašková, Silvie Černík, David Fiksa, Jan Herzig, Roman Jura, René Jurák, Lubomír Klečka, Lukáš Neumann, Jiří Ostrý, Svatopluk Šaňák, Daniel Ševčík, Petr Škoda, Ondřej Šrámek, Martin Tomek, Aleš Václavík, Daniel J Am Heart Assoc Original Research BACKGROUND: The benefit of intravenous thrombolysis is time dependent. It remains unclear, however, whether dramatic shortening of door‐to‐needle time (DNT) among different types of hospitals nationwide does not compromise safety and still improves outcome. METHODS AND RESULTS: Multifaceted intervention to shorten DNT was introduced at a national level, and prospectively collected data from a registry between 2004 and 2019 were analyzed. Generalized estimating equation was used to identify the association between DNT and outcomes independently from prespecified baseline variables. The primary outcome was modified Rankin score 0 to 1 at 3 months, and secondary outcomes were parenchymal hemorrhage/intracerebral hemorrhage (ICH), any ICH, and death. Of 31 316 patients treated with intravenous thrombolysis alone, 18 861 (60%) had available data: age 70±13 years, National Institutes of Health Stroke Scale at baseline (median, 8; interquartile range, 5–14), and 45% men. DNT groups 0 to 20 minutes, 21 to 40 minutes, 41 to 60 minutes, and >60 minutes had 3536 (19%), 5333 (28%), 4856 (26%), and 5136 (27%) patients. National median DNT dropped from 74 minutes in 2004 to 22 minutes in 2019. Shorter DNT had proportional benefit: it increased the odds of achieving modified Rankin score 0 to 1 and decreased the odds of parenchymal hemorrhage/ICH, any ICH, and mortality. Patients with DNT ≤20 minutes, 21 to 40 minutes, and 41 to 60 minutes as compared with DNT >60 minutes had adjusted odds ratios for modified Rankin score 0 to 1 of the following: 1.30 (95% CI, 1.12–1.51), 1.33 (95% CI, 1.15–1.54), and 1.15 (95% CI, 1.02–1.29), and for parenchymal hemorrhage/ICH: 0.57 (95% CI, 0.45–0.71), 0.76 (95% CI, 0.61–0.94), 0.83 (95% CI, 0.70–0.99), respectively. CONCLUSIONS: Ultrashort initiation of thrombolysis is feasible, improves outcome, and makes treatments safer because of fewer intracerebral hemorrhages. Stroke management should be optimized to initiate thrombolysis as soon as possible optimally within 20 minutes from arrival to a hospital. John Wiley and Sons Inc. 2022-05-16 /pmc/articles/PMC9238542/ /pubmed/35574953 http://dx.doi.org/10.1161/JAHA.121.023524 Text en © 2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Mikulík, Robert
Bar, Michal
Bělašková, Silvie
Černík, David
Fiksa, Jan
Herzig, Roman
Jura, René
Jurák, Lubomír
Klečka, Lukáš
Neumann, Jiří
Ostrý, Svatopluk
Šaňák, Daniel
Ševčík, Petr
Škoda, Ondřej
Šrámek, Martin
Tomek, Aleš
Václavík, Daniel
Ultrashort Door‐to‐Needle Time for Intravenous Thrombolysis Is Safer and Improves Outcome in the Czech Republic: Nationwide Study 2004 to 2019
title Ultrashort Door‐to‐Needle Time for Intravenous Thrombolysis Is Safer and Improves Outcome in the Czech Republic: Nationwide Study 2004 to 2019
title_full Ultrashort Door‐to‐Needle Time for Intravenous Thrombolysis Is Safer and Improves Outcome in the Czech Republic: Nationwide Study 2004 to 2019
title_fullStr Ultrashort Door‐to‐Needle Time for Intravenous Thrombolysis Is Safer and Improves Outcome in the Czech Republic: Nationwide Study 2004 to 2019
title_full_unstemmed Ultrashort Door‐to‐Needle Time for Intravenous Thrombolysis Is Safer and Improves Outcome in the Czech Republic: Nationwide Study 2004 to 2019
title_short Ultrashort Door‐to‐Needle Time for Intravenous Thrombolysis Is Safer and Improves Outcome in the Czech Republic: Nationwide Study 2004 to 2019
title_sort ultrashort door‐to‐needle time for intravenous thrombolysis is safer and improves outcome in the czech republic: nationwide study 2004 to 2019
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238542/
https://www.ncbi.nlm.nih.gov/pubmed/35574953
http://dx.doi.org/10.1161/JAHA.121.023524
work_keys_str_mv AT mikulikrobert ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019
AT barmichal ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019
AT belaskovasilvie ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019
AT cernikdavid ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019
AT fiksajan ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019
AT herzigroman ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019
AT jurarene ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019
AT juraklubomir ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019
AT kleckalukas ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019
AT neumannjiri ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019
AT ostrysvatopluk ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019
AT sanakdaniel ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019
AT sevcikpetr ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019
AT skodaondrej ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019
AT sramekmartin ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019
AT tomekales ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019
AT vaclavikdaniel ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019
AT ultrashortdoortoneedletimeforintravenousthrombolysisissaferandimprovesoutcomeintheczechrepublicnationwidestudy2004to2019